Clinical Trials
2 trialsNCT00032513 2026-06-01
Genetic Studies of Chronic Active Epstein-Barr Disease
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03702231 2023-08-04
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed